# Novadip Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novadip-biosciences-s-a

- Industry: Biotechnology
- Headquarters: Mont-Saint-Guibert, Belgium
- Website: www.novadip.com
- Total disclosed funding: $43M
- Latest round: Series B (Feb 21, 2022)
- Investors on record: 10

## About

Founded in 2013 by Denis Dufrane, and Jean- François Pollet, and based in Mont-Saint-Guibert, Belgium, Novadip Biosciences S.A., a spin-off company from Université Catholique de Louvain and St. Luc University Hospital, operates as a clinical-stage biopharmaceutical company that designs and develops a new class of regenerative tissue products to accelerate the healing of large bone defects and injuries. In November 2022, NOVADIP Biosciences S.A. received EUR 16 million of grant funding from investor, The Walloon Region of Belgium.

The company is creating an allogeneic product called NVD-X3 that uses a matrix containing a number of bioactive factors to promote quick tissue healing. Additionally, the company is working on NVD-003, an autologous therapy derived from ASCs, as a potential stand-alone treatment for patients with congenital pseudoarthrosis of the tibia and other uncommon pediatric bone conditions in order to preserve limbs and restore mobility.  

The company intends to use the November 2022 funding to further the creation of orthopedic goods that aid in accelerating recovery following just one surgery.

## Funding rounds

- Series B, Feb 21, 2022, $17M — Vives, Société Régionale d'Investissement de Wallonie, New Science Ventures, CR Capital, Fund+, Investsud
- Series B, Oct 28, 2021, $11M — Vives, Société Régionale d'Investissement de Wallonie, New Science Ventures, Invest.BW, CR Capital, Fund+, Investsud
- Series A, Sep 18, 2015, $16M — Vives, Société Régionale d'Investissement de Wallonie, New Science Ventures, SFPI-FPIM, Invest.BW, Fund+, Epimede, Integrale

## Investors

- Vives (https://capitalatlas.ai/funds/vives) — Series A, Series B
- Société Régionale d'Investissement de Wallonie — Series A, Series B
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B
- SFPI-FPIM — Series A
- Invest.BW (https://capitalatlas.ai/funds/invest-bw) — Series A, Series B
- Fund+ (https://capitalatlas.ai/funds/fund) — Series A, Series B
- Epimede (https://capitalatlas.ai/funds/epimede) — Series A
- Integrale — Series A
- CR Capital (https://capitalatlas.ai/funds/cr-capital) — Series B
- Investsud — Series B